RxDoctor Payments Data

Heidi Holland

Family · Palm Beach Gardens, FLNPI 1023629326

Payments from drug & device makers

$4,608in general payments, 2019–2025

Across 232 payments — averaging $19.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$644
  • Novo Nordisk$621
  • AstraZeneca$478
  • Pfizer$466
  • Lilly USA, LLC$404
  • GSK$322
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$4,58399%
  • Education$251%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,608 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$21,333
Medicare patients
133
Services billed
205

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide33$34,706
MounjaroTirzepatide28$34,120
EliquisApixaban15$18,460
XareltoRivaroxaban11$11,702
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$2,277
Atorvastatin Calcium150$1,138
Rosuvastatin Calcium93$807
Losartan Potassium81$803
Albuterol Sulfate HfaAlbuterol Sulfate42$779
Levothyroxine Sodium93$777
Methylprednisolone101$772
Amlodipine Besylate118$709
Famotidine23$672
Nifedipine ErNifedipine25$642
Omeprazole24$639

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$621$34,70633 claims
Lilly USA, LLCMounjaro$404$34,12028 claims
PfizerEliquis$466$18,46015 claims
Johnson & JohnsonXarelto$34$11,70211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.

Other family in Palm Beach Gardens

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →